CID 16130380
16t oligonucleotide-lipophilic group
Structural Information
- Molecular Formula
- C179H248N34O113P16
- SMILES
- CCCCCCCCCCCCCCCC(=O)NCCCNP(=O)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)OP(=O)(O)OCC3C(CC(O3)N4C=C(C(=O)NC4=O)C)OP(=O)(O)OCC5C(CC(O5)N6C=C(C(=O)NC6=O)C)OP(=O)(O)OCC7C(CC(O7)N8C=C(C(=O)NC8=O)C)OP(=O)(O)OCC9C(CC(O9)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)O
- InChI
- InChI=1S/C179H248N34O113P16/c1-18-19-20-21-22-23-24-25-26-27-28-29-30-32-131(215)180-33-31-34-181-327(248,249)280-68-116-100(36-133(297-116)199-52-84(3)149(217)183-165(199)233)312-329(252,253)282-70-118-102(38-135(299-118)201-54-86(5)151(219)185-167(201)235)314-331(256,257)284-72-120-104(40-137(301-120)203-56-88(7)153(221)187-169(203)237)316-333(260,261)286-74-122-106(42-139(303-122)205-58-90(9)155(223)189-171(205)239)318-335(264,265)288-76-124-108(44-141(305-124)207-60-92(11)157(225)191-173(207)241)320-337(268,269)290-78-126-110(46-143(307-126)209-62-94(13)159(227)193-175(209)243)322-339(272,273)292-80-128-112(48-145(309-128)211-64-96(15)161(229)195-177(211)245)324-341(276,277)294-82-130-114(50-147(311-130)213-66-98(17)163(231)197-179(213)247)326-342(278,279)295-81-129-113(49-146(310-129)212-65-97(16)162(230)196-178(212)246)325-340(274,275)293-79-127-111(47-144(308-127)210-63-95(14)160(228)194-176(210)244)323-338(270,271)291-77-125-109(45-142(306-125)208-61-93(12)158(226)192-174(208)242)321-336(266,267)289-75-123-107(43-140(304-123)206-59-91(10)156(224)190-172(206)240)319-334(262,263)287-73-121-105(41-138(302-121)204-57-89(8)154(222)188-170(204)238)317-332(258,259)285-71-119-103(39-136(300-119)202-55-87(6)152(220)186-168(202)236)315-330(254,255)283-69-117-101(37-134(298-117)200-53-85(4)150(218)184-166(200)234)313-328(250,251)281-67-115-99(214)35-132(296-115)198-51-83(2)148(216)182-164(198)232/h51-66,99-130,132-147,214H,18-50,67-82H2,1-17H3,(H,180,215)(H,250,251)(H,252,253)(H,254,255)(H,256,257)(H,258,259)(H,260,261)(H,262,263)(H,264,265)(H,266,267)(H,268,269)(H,270,271)(H,272,273)(H,274,275)(H,276,277)(H,278,279)(H2,181,248,249)(H,182,216,232)(H,183,217,233)(H,184,218,234)(H,185,219,235)(H,186,220,236)(H,187,221,237)(H,188,222,238)(H,189,223,239)(H,190,224,240)(H,191,225,241)(H,192,226,242)(H,193,227,243)(H,194,228,244)(H,195,229,245)(H,196,230,246)(H,197,231,247)
- InChIKey
- JTLOTDAMJRZVSE-UHFFFAOYSA-N
- Compound name
- N-[3-(hexadecanoylamino)propyl]-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphonamidic acid
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 5178.0583 | 314.8 |
[M+Na]+ | 5200.0402 | 315.0 |
[M-H]- | 5176.0437 | 314.9 |
[M+NH4]+ | 5195.0848 | 314.8 |
[M+K]+ | 5216.0142 | 314.7 |
[M+H-H2O]+ | 5160.0483 | 314.5 |
[M+HCOO]- | 5222.0492 | 314.7 |
[M+CH3COO]- | 5236.0649 | 314.7 |
[M+Na-2H]- | 5198.0257 | 314.8 |
[M]+ | 5177.0505 | 314.9 |
[M]- | 5177.0515 | 314.9 |
Literature stripe
No literature data available for this compound.
Patent stripe
No patent data available for this compound.